PHRMA INC.
Represents leading research-based pharmaceutical and biotechnology companies in the US
Based in DC
🤖
AI Overview
With $2.1M in lobbying spend across 29 quarterly filings, PHRMA INC is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$2.1M
Total Spend
8
Years Active
1
Firms Hired
8
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $300K |
| 2019 | $275K |
| 2020 | $300K |
| 2021 | $300K |
| 2022 | $300K |
| 2023 | $300K |
| 2024 | $300K |
| 2025 | $25K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Medicare/Medicaid, Trade
- •Drug Pricing
- •Drug Pricing
- •CREATES Act
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
GSK (FKA Glaxosmithkline INC.)
$39.9M total spend
Grifols Shared Services North America INC
$8.1M total spend
Alliance for Retired Americans
$2.5M total spend
Biotechnology Innovation Organization (Formerly Biotechnology Industry Org.)
$2.2M total spend
Siemens Healthineers (FKA Varian Medical Systems, INC.)
$1.9M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.